Treatment of cytomegalovirus pneumonia with high-dose acyclovir

Meyers JD, Flournoy N, Thomas ED: Nonbacterial pneumonia after allogeneic marrow transplantation—Review of ten years' experience. Rev Infect Dis (in press). Kraemer, 1978, Prophylactic adenine arabinoside following marrow transplantation, Transplant Proc, 10, 237 Meyers, 1980, Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation, J Infect Dis, 141, 555, 10.1093/infdis/141.5.555 Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED: Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis (in press). Saral, 1981, Acyclovir prophylaxis of herpes-simplex-virus infections: a randomized, double-blind controlled trial in bone-mar-row-transplant recipients, N Engl J Med, 305, 63, 10.1056/NEJM198107093050202 Mitchell, 1981, Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients, Lancet, 1, 1389, 10.1016/S0140-6736(81)92569-1 Chou, 1981, Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections, Lancet, 1, 1389 Wade, 1982, Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial, Ann Intern Med, 96, 265, 10.7326/0003-4819-96-3-265 Selby, 1979, Parenteral acyclovir therapy for herpesvirus infections in man, Lancet, 2, 1267, 10.1016/S0140-6736(79)92281-5 Schaeffer, 1978, 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group, Nature, 272, 583, 10.1038/272583a0 Crumpacker, 1979, Growth inhibition by acycloguanosine of herpesviruses isolated from human infections, Antimicrob Agents Chemother, 15, 642, 10.1128/AAC.15.5.642 Levin, 1981, Inhibition of human herpesviruses by combinations of acyclovir and human leukocyte interferon, Infect Immun, 32, 995, 10.1128/IAI.32.3.995-999.1981 Tyms, 1981, The in vitro activity of acyclovir and related compounds against cytomegalovirus infections, J Antimicrob Chemother, 8, 65, 10.1093/jac/8.1.65 Cupps, 1981, Successful treatment with acyclovir of an immunodeficient patient infected simultaneously with multiple herpesviruses, Am J Med, 70, 882, 10.1016/0002-9343(81)90548-9 McGuffin, 1980, Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro, Antimicrob Agents Chemother, 10, 471, 10.1128/AAC.18.3.471 Thomas, 1975, Bone-marrow transplantation, N Engl J Med, 292, 832, 10.1056/NEJM197504172921605 Thomas, 1975, Bone-marrow transplantation, N Engl J Med, 292, 895, 10.1056/NEJM197504242921706 Singer, 1979, Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro, Blood, 53, 264, 10.1182/blood.V53.2.264.264 Lennette, 1979, 35 Wentworth, 1971, Seroepidemiology of infections due to members of the herpesvirus group, Am J Epidemiol, 94, 496, 10.1093/oxfordjournals.aje.a121347 Hintz, 1979, Field use and validation of the radioimmunoassay for acyclovir (abstr) Quinn, 1979, A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine], Anal Biochem, 98, 319, 10.1016/0003-2697(79)90148-9 Meyers, 1980, Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant, J Infect Dis, 142, 816, 10.1093/infdis/142.6.816 St. Clair, 1980, Inhibition of cellular and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir, Antimicrob Agents Chemother, 18, 741, 10.1128/AAC.18.5.741 Simmons, 1974, Cytomegalovirus: clinical virological correlations in renal transplant recipients, Ann Surg, 180, 623, 10.1097/00000658-197410000-00028 Spector, 1980, Additive and synergistic effects of acyclovir, interferon, phosphonoformic acid and trifluorothymidine against clinical isolates of cytomegalo-virus (abstr) Balfour HH, Bean B, Mitchell CD, Sachs GW, Boen JR, Edelman CK: Acyclovir in immunocompromised patients with cytomegalovirus disease: a controlled trial at one institution. In this supplement 241–248.